knowledge -WSS

knowledge

author：fashion 2025-09-29 21:27:31 - browse：2352

Kidney transplants are the most common organ transplant procedure in the U.S., with 25,000 taking place in 2022. But for patients who receive new kidneys, the transplant is often followed by severe lifelong challenges, many of which are linked to the immunosuppression drug regimen required after surgery to ensure the body does not reject the new organ. These treatments have side effects and toxicities that impact patients’ long-term health, and even survival, leading to a transplant failure rate of 30-50% at the 10-year mark.

Now a new trial sponsored by Medeor Therapeutics, the results of which were presented Thursday at the American Society of Nephrology (ASN) Kidney Week 2023 Annual Meeting, offers hope that stem cell therapy may help patients discontinue their immunosuppressant regime within a year of the transplant.

“The ability to get a transplant without being on lifelong immunosuppression is kind of a dream in transplant, so I can see why this would generate a lot of excitement,” said Sommer Gentry, a professor of surgery at New York University, who was not involved in the study and was not at the actual presentation, but reviewed the trial’s presentation slides.

Get unlimited access to award-winning journalism and exclusive events.

Subscribe Log In

Previous article： Medical leaders decry Supreme Court decision on affirmative action
Next article： ARCH Venture Partners tops STAT's 2023 biotech VC rankings

leisure time

WSS

At Orexo, a ‘turning point’ for everything but digital health

FDA approves RSV monoclonal antibody for infants, toddlers

Cosmetics set for new safety regulation. Why the industry is on board

Teladoc has a new CEO, but challenges remain the same

STAT Virtual Event: ASCO Recap, Live!

Sanders adds drug shortage policies to pandemic preparedness bill

hotspot

knowledge

explore

Heart attack and stroke risk calculators need revising

ARCH Venture Partners tops STAT's 2023 biotech VC rankings

Continuity nursing helped my family in our darkest PICU moments

Key House panel plots a new health care package

Virginia high school admissions case could be legal follow

Deposition: Sackler embraced plan to conceal OxyContin’s strength

Medical leaders decry Supreme Court decision on affirmative action

My daughter's legacy lives on through her writing, phage therapy

Apple is now the first public company to be valued at $3 trillion

ALS patient reclaims some autonomy thanks to wearable 'robot'

hotspot

Doctors find melanoma drugs effective against rare brain cancer

Readers discuss the intersection of pregnancy and addiction

My daughter's legacy lives on through her writing, phage therapy

Report captures long Covid’s disabling effects and policy challenges

The system is set up to fail children with medical complexity

How the BIOSECURE Act is already affecting U.S., Chinese life science firms

Wikipedia

explore

leisure time

Wikipedia